Onderneming Stellar Biotechnologies Inc Nasdaq
Aandelen
CA85855A3029
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Michael Brooks
PSD | President | 46 | 01-09-15 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 15-07-23 |
Blair Gordon
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-16 |
Gary Koppenjan
IRC | Investor Relations Contact | - | 01-01-19 |
Raj Puri
PRN | Corporate Officer/Principal | - | 23-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 07-06-19 |
Frank Oakes
BRD | Director/Board Member | 73 | 09-04-10 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-23 |
Joan Chypyha
BRD | Director/Board Member | 57 | 23-05-23 |
Charles Olson
BRD | Director/Board Member | 66 | 23-05-23 |
Pardeep Nijhawan
FOU | Founder | 53 | 12-06-07 |
Carlo Sistilli
CHM | Chairman | 67 | 07-06-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 3 215 968 | 2 120 255 ( 65,93 %) | 0 | 65,93 % |
Bedrijfsgegevens
![Adres Stellar Biotechnologies Inc](https://cdn.zonebourse.com/static/address/43428073.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 122 mld. | |
+21,96% | 116 mld. | |
+24,51% | 27,03 mld. | |
-20,05% | 20,36 mld. | |
-16,28% | 15,91 mld. | |
-16,40% | 16,43 mld. | |
-44,35% | 15,6 mld. | |
+63,91% | 14,94 mld. | |
+2,52% | 13,59 mld. |